Skip to main content
NewsPortfolioPress ReleasesPrintBio, Inc.Rapha Capital Management

PrintBio Introduces DynaFlex™ Programmable Surgical Mesh (PSM) at American Hernia Society Meeting 2025

By September 5, 2025No Comments
  • DynaFlex™ Incorporates MetaDirectional Flex™ Technology to Create the First-of-Its-Kind Programmable Mesh

Our introduction of DynaFlex™ represents a new era in surgical repair. By giving surgeons programmable control over mesh mechanics, we are setting a new benchmark for innovation in hernia repair”

— Dr. Kevin Slawin, Founder and CEO of PrintBio, and a former surgeon

LONG ISLAND CITY, NY, UNITED STATES, September 4, 2025 /EINPresswire.com/ — PrintBio today announced commencement of its phased commercial rollout of DynaFlex™ Programmable Surgical Mesh (PSM) at the American Hernia Society Annual Meeting, being held September 4–6, 2025, in Nashville, TN.

DynaFlex™ PSM is the first surgical mesh of its kind, designed to be infinitely customizable across multiple clinically relevant dimensions. Its proprietary MetaDirectional Flex™ technology enables the designer to create flexibility and stability in any vector, direction, or zone within the mesh— with potential to deliver personalized reinforcement for each patient.

Unlike category-standard knitted or woven meshes, DynaFlex™ PSM is free of cross-filament knots and weaves which may harbor bacteria. It also has generous interstitial spaces for new tissue growth while protecting those spaces from deformation under strain. By eliminating these structural limitations, DynaFlex™ is engineered to potentially limit contamination and optimize interstitial tissue integration while supporting tissue regeneration for long-term performance.

“Our introduction of DynaFlex™ represents a new era in surgical repair,” said Dr. Kevin Slawin, Founder and CEO of PrintBio, and a former oncologic surgeon. “By giving surgeons programmable control over mesh mechanics, we are addressing unmet clinical needs and setting a new benchmark for innovation in hernia repair.”

The initial phase of commercial rollout at AHS 2025 will include product demonstrations, educational discussions with key opinion leaders, and opportunities for surgeon engagement ahead of full commercialization.

For additional information please visit the PrintBio website at www.printbio.com. To register additional interest, please fill out our Contact Form

Steve Pinto
PrintBio, Inc.
email us here

Rapha Capital Management, LLC is providing this website for informational purposes only. Nothing on this website is intended to constitute, or should be deemed to be, financial advisory, legal, tax, accounting or other professional advice to you or any other party; be an opinion of the appropriateness or suitability of any investment; or constitute an offer to sell or solicitation of an offer to buy any security or investment. This website and its content (collectively, “Content”) is intended for general informational purposes only and should not be acted upon without first obtaining financial advisory, legal, tax, accounting or other professional advice from your consultant or other professional with respect to your own personal investment objectives, financial circumstances and needs. Nothing on the Site shall be considered a recommendation or solicitation to buy or an offer to sell a security to any person in any jurisdiction where such offer, solicitation, purchase or sale would be unlawful under the securities laws of such jurisdiction. Any investment decisions you may make on the basis of any information found on this web site is your sole responsibility. Prior to making any investment or hiring any investment manager you should consult with a professional financial advisor, legal and tax advisor to assist in due diligence as may be appropriate and determining the appropriateness of the risk associated with a particular investment. In no event shall Rapha Capital Management, LLC be responsible or liable for the correctness of any such material or for any damage or lost opportunities resulting from use of these data.